Skip to main content

Table 5 Total Costs of Care for RA Patients at One Year

From: Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

  Infliximab N = 598 Etanercept N = 950 Infliximab: Dose Escalation vs. No Escalation (p-value)
  Dose Escalation No Escalation Dose Escalation No Escalation  
  N = 346 N = 252 N = 172 N = 778  
Measure Cost per patient (mean, SE), $  
RA Related Costs $20,914.98 (631.15) $16,713.20 (1,315.86) $14,482.45 (519.97) $13,865.48 (306.88) <0.0001
   Pharmacy:      
Infliximab $15,997.65 (413.51) $9,999.87 (293.82) $313.88 (175.79) $197.56 (53.23) <0.0001
Etanercept $101.26 (45.32) $178.18 (63.03) $10,426.90 (254.66) $10,099.71 (124.94)  
Other $1,049.00 (69.20) $1,045.57 (145.45) $1,089.33 (88.71) $1,009.24 (48.61)  
Total Pharmacy $17,147.90 (418.81) $11,223.62 (350.97) $11,830.12 (292.80) $11,306.51 (136.87)  
   Outpatient:      
Management $635.68 (53.29) $766.75 (112.25) $377.98 (29.58) $382.19 (41.21)  
Emergency Room $13.85 (4.11) $12.54 (6.32) $4.72 (1.81) $7.09 (1.76)  
Ancillary $1,601.47 (116.33) $1,387.33 (118.42) $842.11 (122.13) $871.60 (90.63)  
Total Outpatient $2,251.00 (136.95) $2,166.62 (176.82) $1,224.81 (135.67) $1,260.88 (120.64)  
   Hospitalization Costs $1,516.08 (393.06) $3,322.95 (1,191.16) $1,427.52 (411.72) $1,298.08 (249.13)  
Non-RA Related Costs $5,370.17 (536.68) $6,104.37 (1,210.40) $3,954.81 (415.94) $4,177.57 (281.46) 0.0302
Grand Total $26,285.15 (1,022.19) $22,817.56 (2,431.57) $18,437.26 (809.69) $18,043.04 (496.95) <0.0001